Knowledge-based approach to identify key determinants of cisplatin sensitivity
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
International journal of clinical pharmacology and therapeutics - 55(2017), 8 vom: 01. Aug., Seite 686-689 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sarin, Navin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 26.09.2017 Date Revised 26.09.2017 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.5414/CPXCES15EA04 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM264449533 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM264449533 | ||
| 003 | DE-627 | ||
| 005 | 20231224210120.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5414/CPXCES15EA04 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0881.xml |
| 035 | |a (DE-627)NLM264449533 | ||
| 035 | |a (NLM)27641214 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sarin, Navin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Knowledge-based approach to identify key determinants of cisplatin sensitivity |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.09.2017 | ||
| 500 | |a Date Revised 26.09.2017 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Cisplatin |2 NLM | |
| 650 | 7 | |a Q20Q21Q62J |2 NLM | |
| 700 | 1 | |a Engel, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Kalayda, Ganna V |e verfasserin |4 aut | |
| 700 | 1 | |a Frötschl, Roland |e verfasserin |4 aut | |
| 700 | 1 | |a Cinatl, Jindrich |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Rothweiler, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Michaelis, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Fröhlich, Holger |e verfasserin |4 aut | |
| 700 | 1 | |a Jaehde, Ulrich |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of clinical pharmacology and therapeutics |d 1997 |g 55(2017), 8 vom: 01. Aug., Seite 686-689 |w (DE-627)NLM075091739 |x 0946-1965 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2017 |g number:8 |g day:01 |g month:08 |g pages:686-689 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5414/CPXCES15EA04 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2017 |e 8 |b 01 |c 08 |h 686-689 | ||